<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Bach Noble | Activity</title>
	<link>https://recash.wpsoul.net/members/citypaul63/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/citypaul63/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Bach Noble.</description>
	<lastBuildDate>Thu, 06 Aug 2026 00:40:21 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">1a4e01ad003b272f2836154c8e9a54ea</guid>
				<title>Bach Noble posted an update: No difference in survival after same- or next-day sentinel [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/168600/</link>
				<pubDate>Sun, 12 Jan 2025 10:23:04 +0000</pubDate>

									<content:encoded><![CDATA[<p>No difference in survival after same- or next-day sentinel node biopsy is seen when </p>
<p> Tc-labelled antimony sulphide colloid is used. This may be because of less tracer migration to second-tier nodes.</p>
<p>No difference in survival after same- or next-day sentinel node biopsy is seen when 99m Tc-labelled antimony sulphide colloid is used. This may&hellip;<span class="activity-read-more" id="activity-read-more-168600"><a href="https://recash.wpsoul.net/activity/p/168600/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">09e97361c345cc108617a41044418e70</guid>
				<title>Bach Noble posted an update: In stage 3, a minimization approach was used to add 20 more [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/151159/</link>
				<pubDate>Mon, 06 Jan 2025 10:59:11 +0000</pubDate>

									<content:encoded><![CDATA[<p>In stage 3, a minimization approach was used to add 20 more sites to the trial. A standardized metric based on the half-normal distribution of the absolute value of mean differences was used to assess site imbalance. <a href="https://www.selleckchem.com/products/Nevirapine(Viramune).html" rel="nofollow ugc">NSC 641530 supplier</a> After stage 3, the remaining imbalance for the 49 enrolled sites was reduced by 75% from what would have been&hellip;<span class="activity-read-more" id="activity-read-more-151159"><a href="https://recash.wpsoul.net/activity/p/151159/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">51e6ba7dd8e0529cfb51c750d2485317</guid>
				<title>Bach Noble became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/149467/</link>
				<pubDate>Mon, 06 Jan 2025 02:32:54 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>